CG Oncology, Inc. Common stock Earnings
The next earnings date for CG Oncology, Inc. Common stock is November 18, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of CG Oncology, Inc. Common stock Earnings
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
CG Oncology, Inc. Common stock Earnings: Historical
More About CG Oncology, Inc. Common stock
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003, which is in phase 3 clinical trial for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 that is in phase 2 clinical trial to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy that is in phase 3 clinical trial for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008, which is in phase 2 clinical trial for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
“CG Oncology, Inc. Common stock Earnings” Can Refer to the CG Oncology, Inc. Common stock Earnings Date
Some people say “CG Oncology, Inc. Common stock earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my CG Oncology, Inc. Common stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning CG Oncology, Inc. Common stock Stock on the Earnings Date
If you own CG Oncology, Inc. Common stock stock (CGON) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for CG Oncology, Inc. Common stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading CG Oncology, Inc. Common stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More CG Oncology, Inc. Common stock Earnings
You can contact us any time if you would like to ask questions about CG Oncology, Inc. Common stock earnings or anything else related to the stock market.